MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

EEG Markers for Emotional Inhibition in Parkinson’s Disease

N. Dissanayaka, D. Hennessy, T. Au, A. Angwin, J.H. Yang, J. O'Sullivan, D. Copland (Brisbane, Australia)

Meeting: 2017 International Congress

Abstract Number: 1527

Keywords: Electroencephalogram(EEG), Parkinsonism

Session Information

Date: Thursday, June 8, 2017

Session Title: Parkinson's Disease: Neuroimaging And Neurophysiology

Session Time: 1:15pm-2:45pm

Location: Exhibit Hall C

Objective: This study aims to advance understanding of neural mechanisms in Parkinson’s disease (PD) using event related potentials (ERPs) generated during emotional response inhibition and to establish ERP markers for detection and monitoring of progressive neural changes.

Background: There is a need for better diagnostics and monitoring of neural and cognitive changes during the progression of PD. In previous literature, neural disruptions to emotional processing in PD have been reported.1 A non-invasive method to study such neural changes is to record ERPs in an EEG during participation in a cognitive task.

Methods: Twenty-two non-demented PD patients and 13 healthy age matched controls were tested using a visual Go/Nogo task with affective words (positive, negative, and neutral) as distractors and targets whilst ERPs were recorded.

Results: Behavioural findings and ERPs differentiated PD from healthy older people: (i) PD took consistently longer to respond to targets across all conditions (F1, 29 = 9.30, p = .005), and were significantly less accurate in both Go and Nogo trials (F1, 29 = 5.70, p = .024); (ii) N2 amplitude was significantly higher (F1, 33 = 6.15, p = .018), and P3 amplitude was significantly lower (F1, 33 = 4.95, p = .033) and occurred significantly later in PD (F1, 33 = 6.0, p =.019). Support for ERP differentiation due to affective valence between PD and controls was not observed, however, these results and a consideration of study limitations provide new directions for future research.

Conclusions: This study has provided support for the utility of N2 and P3 recordings during participation in an affective Go/Nogo task as potential biomarkers of PD progression and diagnosis.

References: Peron et al. 2012 Movement Disorders. V27(2): p186-199

To cite this abstract in AMA style:

N. Dissanayaka, D. Hennessy, T. Au, A. Angwin, J.H. Yang, J. O'Sullivan, D. Copland. EEG Markers for Emotional Inhibition in Parkinson’s Disease [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/eeg-markers-for-emotional-inhibition-in-parkinsons-disease/. Accessed May 16, 2025.
  • Tweet
  • Email
  • Print

« Back to 2017 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/eeg-markers-for-emotional-inhibition-in-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley